24 X 7 Live Chat SUPPORT

Femara

Femara

Availability: In stock

$4.23
Femara (Letrozole) is for oral administration. It is generally considered as an extended adjuvant treatment of early breast cancer in postmenopausal women, who have received 5 years of adjuvant tamoxifen therapy. This aromatase inhibitor kills cancer cells that are dependent on estrogen level for blooming.
Quantity Strength Unit Price Price Cart
30 tab Femara Generic Letrozole Tablets $4.23 $126.99
90 tab Femara Generic Letrozole Tablets $4.23 $380.99

Details

Medication for breast cancer develops under the influence of female sex hormone estrogen that is secreted by the ovary. This relationship of breast cancer risk and estrogen (female hormone responsible for normal functioning of the female organs and their growth) is evidently proven by various researches in the field. Moreover, the thriving clinical strategy of treating breast cancer by blocking estrogen action using the anti-estrogen or preventing estrogen synthesis using aromatase inhibitors is proving beneficial for post-menopausal women's health. Generic name is Letrozole, which is a non-steroidal aromatase inhibitor. Aromatase is an enzyme that standardizes the making of estrogen. This property to block the production of estrogen makes it an advance healing solution for breast cancer in postmenopausal women. Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is stimulated by hormone.

FAQ about Femara (Letrozole)

 How Femara (Letrozole) works? Letrozole is a type of drug called an aromatase inhibitor. Aromatase inhibitors work by limiting the ability of an enzyme called aromatase to create estrogen - a major growth factor in hormone-receptor positive breast cancers. These drugs have been shown to almost completely suppress estrogen levels in post-menopausal women.  How is letrozole different from tamoxifen? Letrozole suppresses the production of estrogen. Tamoxifen has no effect on the production of estrogen. Rather, it prevents the binding of estrogens to the estrogen-receptors of the cancer cells and therefore blocks the stimulation of the tumour. One study looked at the drug's effectiveness as an adjuvant treatment of early breast cancer. Adjuvant therapy for breast cancer is treatment that follows breast cancer surgery(with or without radiation). It is given to help prevent the cancer from returning. These studies compared Femara with tamoxifen in postmenopausal women with early cancer. Taking Femara reduced the chances of the cancer returning by up to 17 percent when compared to tamoxifen.  Should women taking another aromatase inhibitor (such as anastrozole [Arimidex] or exemestane [Aromasin]) switch to letrozole? Researchers do not have data to determine if women taking another aromataase inhibitor should switch to letrozole. On October 5, 2005, the FDA approved exemestane tablets (Aromasin, a product of Pfizer Inc.) for adjuvant treatment of postmenopausal women with estrogen receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to exemestane for completion of a total of five consecutive years of adjuvant hormonal therapy.  Can pre-menopausal breast cancer survivors take this drug? No. Letrozole is not effective for pre-menopausal women. In pre-menopausal women, the predominant source of estrogen is the ovaries. Letrozole does not work to suppress the production of estrogen from the ovaries.  How do I can reduce risk of breast cancer? Lifestyle and diet are among the biggest external factors that stimulates the risk of this insidious disease. By adopting a healthy life style the risk of breast cancer can be reduced. The benefits of exercises such as brisk walking, jogging are evidently proven for all groups. Other than this avoid alcohol, smoking and unhealthy eating. Physical work can help you maintain healthy weight.  What are the alarming symptoms of breast cancer? Earlier the prognosis, smoother the treatment! Breast cancer symptoms are generally overlooked till the tumor developed. If Self-examining of breast shows following signs you should consult your doctor:  A lump in the breast or underarm that persists even after your menstrual cycle. This is often the first apparent symptom of breast cancer. Lumps are usually visible on a mammogram long before they can be seen or felt.  Any change in the size, contour, texture, or temperature of the breast. A reddish, pitted surface like the skin of an orange could be a sign of advanced breast cancer.  Unusual discharge from the nipple that may be clear, bloody, or another color. It's usually caused by benign conditions but could be due to cancer in some cases.  An area that is distinctly different from any other area on either breast. People may also visit following links http://www.cancer.gov. http://www.cancer.gov/newscenter/pressreleases/letrozole. http://www.cancer.gov/newscenter/qa/2003/letrozoletamoxifenqandA http://content.nejm.org/cgi/content/full/349/19/1793 http://breast-cancer.emedtv.com/femara/femara-p2.html

Write Your Own Review Here

You're reviewing: Femara

How do you rate this product? *

  1 star 2 stars 3 stars 4 stars 5 stars
Price
Quality
Value

Additional Information

Generic Letrozole
Strength Femara Generic Letrozole Tablets
Dosage No
Side Effects No
Precaution No

Write Your Own Review Here

You're reviewing: Femara

How do you rate this product? *

  1 star 2 stars 3 stars 4 stars 5 stars
Price
Quality
Value